Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 4—April 2007
Letter

Isolation of Schineria sp. from a Man

On This Page
Figures
Article Metrics
26
citations of this article
EID Journal Metrics on Scopus

Cite This Article

To the Editor: Schineria larvae has been isolated from maggots of the fly Wohlfahrtia magnifica (1), which cause myiasis in animals and people in Eurasia and northern Africa. In industrialized nontropical countries, a range of species in the order Diptera cause facultative myiasis in patients with neglected wounds (2). Since the recent description of S. larvae, Schineria sp. isolates and clones have been detected in diverse environmental and animal sources, but in all cases a relation with flies could be established. We describe a case of bacteremia due to Schineria sp. in a human patient with myiasis.

In July 2005, a 39-year-old homeless man with medical history of polyneuropathy related to alcohol abuse was examined at Montpellier Hospital, Montpellier, France, and found to be in poor general health and to have an abnormal electrocardiogram, mild fever (38°C), metabolic disorders, increased C-reactive protein (254 mg/L) and fibrinogen (18.23 µmol/L), and a normal leukocyte count (7.8 × 109/L). Removal of his shoes and socks, which he had worn continuously for 2 months, showed advanced maceration of his feet (trench foot) with wounds invaded by maggots. The following organisms were found in wound samples: Proteus mirabilis, Providentia stuartii, group G Streptococcus, Streptococcus sp., and Enterococcus sp. Aerobic blood culture, after 2 days of incubation, was positive for a gram-negative rod, strain ADV1107.05. Subculture on MacConkey medium showed positive reactions for oxydase, catalase, and gamma-glutamyltransferase. Positive malate reaction with API 20NE system (bioMérieux, Marcy l’Etoile, France) identified the strain as Oligella urethralis, whereas VITEK2 (bioMérieux) with ID-GN card failed to identify the strain. Disk diffusion assay showed the strain to be susceptible to β-lactams, aminoglycosides, fluoroquinolones, tetracyclines, erythromycin, rifampin, and colistin but resistant to nalidixic acid and fosfomycin. Local therapy of debridement, bandaging, and sulfadiazin argentic, along with systemic antimicrobial therapy (ofloxacin 400 mg/day plus cefotaxime 6g/day) for 2 weeks, led to clinical improvement and sterilization of the blood cultures. The local therapy was continued, and ofloxacin (400 mg/day) was prescribed for 15 days while the patient was in a rehabilitation center.

In October 2005, the patient was readmitted with the same symptoms. P. mirabilis, group A and group G streptococci, Morganella sp., Bacteroides fragilis, and Candida albicans were cultured from maggot-invaded wounds. Aerobic blood culture, after 1 day of incubation, was positive for strain ADV4155.05, which displayed the same phenotype as strain ADV1107.05 except for tetracycline resistance. Clinical improvement was observed after 2 weeks of the same local and systemic treatments as initially prescribed. The patient was transferred to an addiction care center and received oral antimicrobial therapy (ciprofloxacin 500 mg/day plus amoxicillin/clavulanic acid 3 g/day) for 20 days.

Figure

Thumbnail of Maximum likelihood (ML) 16S rRNA gene phylogenetic tree showing the placement of the genus Schineria (boldface) and the isolate ADV1107.05 (underlined) in the phylum Proteobacteria. To reconstruct this tree, we used the strain ADV1107.05 sequence (DQ906159, 1441 bp) and 49 sequences selected from the GenBank database: 38 among the 15 orders of the Gamma Proteobacteria, 6 for the Beta Proteobacteria, 2 for the Alpha Proteobacteria, 1 for Delta Proteobacteria, 1 for Epsilon Proteobacteria and Clostridium haemolyticum (used as the outgroup organism). Accession nos. are in brackets. Alignment was performed with ClustalW 1.83 (4). ML phylogenetic analysis was performed by using PHYML v2.4.4 (5) with the general time-reversible plus gamma distribution plus invariable site (GTR + Γ + I) model found to be most appropriate according to Akaike information criteria. Bootstrap values given at the nodes are estimated with 100 replicates. The scale bar indicates 0.3 substitutions per nucleotide position. Strain ADV4155.05 sequence (DQ906158, 1414 bp) is not reported because it was identical to ADV1107.05. Trees were also obtained by distance methods (JC69, F84, and GTR models, and neighbor-joining), by parsimony, and by Bayesian inference. In all instances the genus Schineria branched out of the Xanthomonadaceae cluster.

Figure. Maximum likelihood (ML) 16S rRNA gene phylogenetic tree showing the placement of the genus Schineria (boldface) and the isolate ADV1107.05 (underlined) in the phylum Proteobacteria. To reconstruct this tree, we...

The 16S rDNA amplification and sequencing were performed with universal primers 27f and 1492r as described (3). The 1,414-bp sequences of the 2 isolates were identical and showed similarity level of 99.6% with the sequence of Schineria sp. 010793816 isolated from human urine (M. Vaneechoutte, pers. comm.) but only 98.3% with S. larvae L1/68T 16S rDNA. This finding differed from the biochemical identification and underlined the usefulness of sequencing to precisely identify gram-negative bacilli that assimilate only a few sugars. Phylogenetic analysis linked the 2 strains to the genus Schineria in the class Gamma Proteobacteria (Figure). However, whether the isolates are species S. larvae remains in doubt. Enterobacterial repetitive intergenic consensus–PCR and repetitive extragenic palindromic–PCR fingerprints (6) showed that the 2 strains were unrelated, thereby demonstrating that the second episode of bacteremia was a reinfection with a new strain and not a relapse.

The 16S rDNA of our isolates is most related to an uncultured bacterium found in swine waste (7), but its presence in such an environment could be correlated with fly larvae proliferation. Because of the lifestyle of Schineria sp., thinking that the strains in our patient originated from his wounds’ maggots is reasonable. Unfortunately, the maggots were thrown away and could be neither analyzed nor identified. Schineria sp. could not be cultivated from the patient’s wounds, perhaps because of its close association to larvae or to the abundant associated flora. Despite the presence of virulent bacteria in the wounds, Schineria sp. was the sole bacterium recovered from blood during the 2 independent episodes of bacteremia, which suggests its invasive potential. Invasiveness may be enhanced by the maggots’ acting as a vector as they move through the necrotic tissues toward the bloodstream. Invasiveness also may be a specific characteristic of the bacterium; phylogenetic methods placed the genus Schineria in a subgroup that included human pathogens Cardiobacterium, Francisella, Coxiella, and Legionella. Indeed, all the phylogenetic methods tested excluded Schineria spp. of the family Xanthomonadaceae (Figure), which conflicts with current classification (8).

No report has described bacteremia following myiasis with facultative parasites, but investigations of bacteria in reported myiasis cases have been conducted on cutaneous lesions and never on blood (9). Because of this association between maggots and risk for bacteremia, blood cultures should be performed for patients with myiasis and poor hygiene. Moreover, germ-free maggots bred for biosurgery use (10) should be checked, by molecular methods, for the absence of Schineria sp.

Top

Laurent Roudiere*, Hélène Jean-Pierre†, Christine Comte†, Isabelle Zorgniotti*, Hélène Marchandin†, and Estelle Jumas-Bilak*Comments to Author 
Author affiliations: *University Montpellier 1, Montpellier, France; †Centre Hospitalier Universitaire de Montpellier, Montpellier, France;

Top

References

  1. Toth  E, Kovacs  G, Schumann  P, Kovacs  AL, Steiner  U, Halbritter  A, Schineria larvae gen. nov., sp. nov., isolated from the 1st and 2nd larval stages of Wohlfahrtia magnifica (Diptera: Sarcophagidae). Int J Syst Evol Microbiol. 2001;51:4017.PubMedGoogle Scholar
  2. Delhaes  L, Bourel  B, Scala  L, Muanza  B, Dutoit  E, Wattel  F, Case report: recovery of Calliphora vicina first-instar larvae from a human traumatic wound associated with a progressive necrotizing bacterial infection. Am J Trop Med Hyg. 2001;64:15961.PubMedGoogle Scholar
  3. Teyssier  C, Marchandin  H, Jean-Pierre  H, Diego  I, Darbas  H, Jeannot  JL, Molecular and phenotypic features for identification of the opportunistic pathogens Ochrobactrum spp. J Med Microbiol. 2005;54:94553. DOIPubMedGoogle Scholar
  4. Thompson  JD, Higgins  DG, Gibson  TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994;22:467380. DOIPubMedGoogle Scholar
  5. Guindon  S, Gascuel  O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol. 2003;52:696704. DOIPubMedGoogle Scholar
  6. Versalovic  J, Koeuth  T, Lupski  JR. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res. 1991;19:682331. DOIPubMedGoogle Scholar
  7. Juteau  P, Tremblay  D, Villemur  R, Bisaillon  JG, Beaudet  R. Analysis of the bacterial community inhabiting an aerobic thermophilic sequencing batch reactor (AT-SBR) treating swine waste. Appl Microbiol Biotechnol. 2004;66:11522. DOIPubMedGoogle Scholar
  8. Saddler  GS, Bradbury  JF. Family I. Xanthomonadaceae fam. nov. In: Brenner DJ, Krieg NR, Staley JT, Garrity GM, editors. Bergey’s manual of systematic bacteriology. 2nd ed. Vol. 2. New York: Springer; 2005. p. 63.
  9. Mallon  PW, Evans  M, Hall  M, Bailey  R. Something moving in my head. Lancet. 1999;354:1260. DOIPubMedGoogle Scholar
  10. Nuesch  R, Rahm  G, Rudin  W, Steffen  I, Frei  R, Rufli  T, Clustering of bloodstream infections during maggot debridement therapy using contaminated larvae of Protophormia terraenovae. Infection. 2002;30:3069. DOIPubMedGoogle Scholar

Top

Figure

Top

Cite This Article

DOI: 10.3201/eid1304.061255

Related Links

Top

Table of Contents – Volume 13, Number 4—April 2007

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Estelle Jumas-Bilak, University Montpellier 1, UFR des Sciences Pharmaceutiques, BP 14491 Laboratoire de Bactériologie EA 3755 15, Avenue Charles Flahault F-34093 Montpellier, Cedex 5 France;

Send To

10000 character(s) remaining.

Top

Page created: June 28, 2010
Page updated: June 28, 2010
Page reviewed: June 28, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external